Human immunology and immunotherapy: main achievements and challenges

被引:119
作者
Varade, Jezabel [1 ,2 ]
Magadan, Susana [1 ,2 ]
Gonzalez-Fernandez, Africa [1 ,2 ]
机构
[1] Univ Vigo, Immunol Grp, Ctr Invest Biomed, CINBIO, Campus Univ Lagoas, Vigo 36310, Spain
[2] SERGAS UVIGO, Inst Invest Sanitaria Galicia Sur IIS Galica Sur, Vigo, Spain
关键词
Vaccines; CAR T cells; Trained immunity; Microbiota; Cancer; Monoclonal antibodies; INNATE LYMPHOID-CELLS; REGULATORY T-CELLS; NATURAL-KILLER-CELLS; CONVALESCENT PLASMA THERAPY; HUMAN MONOCLONAL-ANTIBODIES; GUT MICROBIOTA; TRANSCRIPTION FACTOR; NEXT-GENERATION; DENDRITIC CELLS; IMMUNE-SYSTEM;
D O I
10.1038/s41423-020-00530-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The immune system is a fascinating world of cells, soluble factors, interacting cells, and tissues, all of which are interconnected. The highly complex nature of the immune system makes it difficult to view it as a whole, but researchers are now trying to put all the pieces of the puzzle together to obtain a more complete picture. The development of new specialized equipment and immunological techniques, genetic approaches, animal models, and a long list of monoclonal antibodies, among many other factors, are improving our knowledge of this sophisticated system. The different types of cell subsets, soluble factors, membrane molecules, and cell functionalities are some aspects that we are starting to understand, together with their roles in health, aging, and illness. This knowledge is filling many of the gaps, and in some cases, it has led to changes in our previous assumptions; e.g., adaptive immune cells were previously thought to be unique memory cells until trained innate immunity was observed, and several innate immune cells with features similar to those of cytokine-secreting T cells have been discovered. Moreover, we have improved our knowledge not only regarding immune-mediated illnesses and how the immune system works and interacts with other systems and components (such as the microbiome) but also in terms of ways to manipulate this system through immunotherapy. The development of different types of immunotherapies, including vaccines (prophylactic and therapeutic), and the use of pathogens, monoclonal antibodies, recombinant proteins, cytokines, and cellular immunotherapies, are changing the way in which we approach many diseases, especially cancer.
引用
收藏
页码:805 / 828
页数:24
相关论文
共 332 条
[61]   NEUROIMMUNE INTERACTIONS: FROM THE BRAIN TO THE IMMUNE SYSTEM AND VICE VERSA [J].
Dantzer, Robert .
PHYSIOLOGICAL REVIEWS, 2018, 98 (01) :477-504
[62]   Genetics of immune-mediated inflammatory diseases [J].
David, T. ;
Ling, S. F. ;
Barton, A. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 193 (01) :3-12
[63]   An Update on Autoinflammatory Diseases: Interferonopathies [J].
Davidson, Sophia ;
Steiner, Annemarie ;
Harapas, Cassandra R. ;
Masters, Seth L. .
CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (07)
[64]   Natural Killer Cell Adoptive Transfer Therapy Exploiting the First Line of Defense Against Cancer [J].
Davis, Zachary B. ;
Felices, Martin ;
Verneris, Michael R. ;
Miller, Jeffrey S. .
CANCER JOURNAL, 2015, 21 (06) :486-491
[65]   Oncolytic viruses: how "lytic" must they be for therapeutic efficacy? [J].
Davola, Maria Eugenia ;
Mossman, Karen Louise .
ONCOIMMUNOLOGY, 2019, 8 (06)
[66]   Non-specific effects of vaccines: Current evidence and potential implications [J].
de Bree, L. C. J. ;
Koeken, Valerie A. C. M. ;
Joosten, Leo A. B. ;
Aaby, Peter ;
Benn, Christine Stabell ;
van Crevel, Reinout ;
Netea, Mihai G. .
SEMINARS IN IMMUNOLOGY, 2018, 39 (0C) :35-43
[67]   The prevention of infection-associated cancers [J].
De Flora, Silvio ;
Bonanni, Paolo .
CARCINOGENESIS, 2011, 32 (06) :787-795
[68]   Novel proteasome assembly chaperone mutations in PSMG2/PAC2 cause the autoinflammatory interferonopathy CANDLE/PRAAS4 [J].
de Jesus, Adriana A. ;
Brehm, Anja ;
VanTries, Rachel ;
Pillet, Pascal ;
Parentelli, Anne-Sophie ;
Sanchez, Gina A. Montealegre ;
Deng, Zuoming ;
Paut, Isabelle Kone ;
Goldbach-Mansky, Raphaela ;
Krueger, Elke .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (05) :1939-+
[69]   Translational Mini-Review Series on Th17 Cells: Development of mouse and human T helper 17 cells [J].
de Jong, E. ;
Suddason, T. ;
Lord, G. M. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 159 (02) :148-158
[70]   Bioimmunoadjuvants for the treatment of neoplastic and infectious disease: Coley's legacy revisited [J].
Decker, William K. ;
Safdar, Amar .
CYTOKINE & GROWTH FACTOR REVIEWS, 2009, 20 (04) :271-281